Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

XENE holding history

Xenon Pharmaceuticals Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

XENE overviewAll 13F holders of XENEFull Q2 2026 holdings

Shares (Q2 2026)
223,922
Value
$13.5M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of XENE by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026223,922$13.5M<0.1%+204,982+1,082.3%AddedHolders
Q1 202618,940$1.10M<0.1%−11,911−38.6%ReducedHolders
Q4 202530,851$1.38M<0.1%−17,604−36.3%ReducedHolders
Q3 202548,455$1.95M<0.1%−93,328−65.8%ReducedHolders
Q2 2025141,783$4.44M<0.1%−10,405−6.8%ReducedHolders
Q1 2025152,188$5.11M<0.1%+65,215+75.0%AddedHolders
Q4 202486,973$3.41M<0.1%−117,919−57.6%ReducedHolders
Q3 2024204,892$8.07M<0.1%+43,170+26.7%AddedHolders
Q2 2024161,722$6.31M<0.1%−36,804−18.5%ReducedHolders
Q1 2024198,526$8.55M<0.1%+114,373+135.9%AddedHolders
Q4 202384,153$3.88M<0.1%+43,606+107.5%AddedHolders
Q3 202340,547$1.39M<0.1%−58,198−58.9%ReducedHolders
Q2 202398,745$3.80M<0.1%−107,927−52.2%ReducedHolders
Q1 2023206,672$7.40M<0.1%−153,749−42.7%ReducedHolders
Q4 2022360,421$14.2M<0.1%−49,142−12.0%ReducedHolders
Q3 2022409,563$14.8M<0.1%+83,021+25.4%AddedHolders
Q2 2022326,542$9.93M<0.1%−3,985−1.2%ReducedHolders
Q1 2022330,527$10.1M<0.1%−144,613−30.4%ReducedHolders
Q4 2021475,140$14.8M<0.1%+326,261+219.1%AddedHolders
Q3 2021148,879$2.27M<0.1%−15,192−9.3%ReducedHolders
Q2 2021164,071$3.06M<0.1%−10,924−6.2%ReducedHolders
Q1 2021174,995$3.13M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.